Browsing by Author Hurwitz, H

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 7 to 12 of 12 < previous 
TitleAuthor(s)Issue Date
 
Modulation of angiogenic biomarkers in patients receiving high-dose TRC105
Proceeding/Conference:Journal of Clinical Oncology
Liu, YStarr, MBrady, JCPang, HMHDellinger, ALeigh, BRTheuer, CPHurwitz, HNixon, AB
2012
 
Modulation of angiogenic biomarkers in patients treated on a phase I study of TRC105 (anti-CD105 antibody) monotherapy for advanced solid tumors
Proceeding/Conference:Journal of Clinical Oncology
Liu, YStarr, MPang, HMHMarcello, JLeigh, BRTheuer, CPHurwitz, HNixon, AB
2011
 
Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors
Proceeding/Conference:Journal of Clinical Oncology
Jia, JLi, HDellinger, APang, HMHRussell, KBHurwitz, HNixon, AB
2012
 
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303
Proceeding/Conference:Journal of Clinical Oncology
Nixon, ABPang, HMHStarr, MHollis, DFriedman, PNBertagnolli, MMKindler, HLGoldberg, RMVenook, APHurwitz, H
2011
 
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)
Proceeding/Conference:Journal of Clinical Oncology
Hatch, AJPang, HMHStarr, MDBrady, JCJia, JChen, JSibley, AOwzar, KNiedzwiecki, DVenook, APCushman, SMHurwitz, HNixon, AB
2014
 
Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A)
Proceeding/Conference:Journal of Clinical Oncology
Nixon, AStarr, MPang, HMHBulusu, AHoneycutt, WAmara, ABendell, JCHurwitz, H
2010
Showing results 7 to 12 of 12 < previous